I don't understand. This Cancer Drug is being tested and tried for people with MS. That is all well and good, for those that might need it. I have been on "low dose Naltrexone" since April 2006 and have not had a relapse since and my neuro says I am his only patient that is not progressing. But it is like pulling teeth to get the medical community behing Naltrexone. I am not saying it will work for all....but for some it could possibly help and with very few side affects. I really wonder about what the logic is with this. I just know so far it has worked for me!
Nowadays, there have been many drugs/ medication or treatment that promises to work well with people who have been suffering from cancer. Well, it's good to know though sometimes it becomes confusing at all. Art and Meditation for Cancer Patients is another promising method that has been tested and proven to have beneficial effect to patients.
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2013 Remedy Health Media, LLC. All Rights Reserved.
Test Your MS Knowledge 
Even More Famous Faces with Multiple Sclerosis! 
10 Foods That Fight Inflammation 
Unusual Multiple Sclerosis Symptoms 
Dr. Kantor,
With the NEJM (New England Journal of Medicine) article highlighting the trial of Campath (alemtuzumab) against Rebif (interferon beta 1-a), there has been increased interest in using Campath to fight MS. In fact with the press releases in Oct 2008, many of us have been asked to spread the word.
My question to you - In my researching of the topic, I read a report which came out of the Montreal MS World Congress meeting in which a researcher (or someone connected to the research) said that the person who DID die of ITP was found to be in the Rebif arm of the trial.
Since I do not have professional access to the NEJM, could you clarify or confirm that indeed the person who died from ITP was taking Rebif or Campath? If it were from Rebif, why hasn't that information been included in the press releases?
As a patient, what is the easiest way to research the adverse side-effects (including death) of patients taking the various approved and experiemental drugs?
I appreciate any information which you could share on the topics above. Thanks.